West Pharmaceutical Services Inc (WST)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 574,500 575,800 591,800 643,500 676,000 613,700 575,500 621,400 655,800 741,200 783,500 766,400 752,300 684,400 602,200 494,500 406,900 368,900 337,000 313,900
Total assets US$ in thousands 3,643,400 3,675,100 3,489,400 3,602,300 3,829,500 3,754,700 3,669,600 3,723,600 3,616,800 3,316,800 3,361,700 3,294,700 3,313,800 3,142,600 2,933,500 2,739,700 2,793,800 2,582,800 2,392,300 2,246,500
Operating ROA 15.77% 15.67% 16.96% 17.86% 17.65% 16.34% 15.68% 16.69% 18.13% 22.35% 23.31% 23.26% 22.70% 21.78% 20.53% 18.05% 14.56% 14.28% 14.09% 13.97%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $574,500K ÷ $3,643,400K
= 15.77%

The operating return on assets (operating ROA) for West Pharmaceutical Services Inc has shown a generally positive trend from March 2020 to December 2024. The operating ROA increased steadily from 13.97% in March 2020 to a peak of 23.31% in June 2022, indicating efficient utilization of assets to generate operating income.

However, after reaching its peak in June 2022, the operating ROA started to decline gradually. By December 2024, the operating ROA decreased to 15.77%, reflecting a decrease in the company's operating efficiency in generating profits from its assets compared to the previous periods.

It is important for West Pharmaceutical Services Inc to monitor and potentially address this decline in operating ROA to ensure sustained profitability and operational performance in the future. Understanding the factors contributing to the decrease in operating ROA will be crucial for the company to make informed decisions and implement strategies to improve efficiency and enhance financial performance.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating ROA
West Pharmaceutical Services Inc
WST
15.77%
Carlisle Companies Incorporated
CSL
19.50%